FDA ApprovedUnited States
Monthly Shot to Lower Triglycerides and Pancreatitis Risk
Tryngolza (olezarsen) — ApoC-III ASO for severe hypertriglyceridemia (sHTG) and FCS
FDA sHTG expansion 24 Jun 2026; first labelled pancreatitis-risk reduction in sHTG; FCS since 2024
This is for adults with severe hypertriglyceridemia (fasting TG 500 mg/dL or higher) — and caregivers — who need a labelled way to lower triglycerides and cut…